Tarsons Products Limited , a leading player in the life sciences industry, has announced significant changes to its board composition, effective August 4, 2025. The company has made strategic moves to strengthen its leadership team with new appointments while bidding farewell to a long-standing board member.

Key Board Changes

Dr. Monjori Mitra

Appointed as Additional Director (Non-Executive Independent)

• Brings 24 years of experience in infectious diseases and pediatrics
• Holds MBBS, D.C.H. in Child Health, and DNB in Pediatrics
• Renowned for conducting clinical studies and publishing in indexed journals

Mr. Ramanathan Subramanian Arun Kumar

Appointed as Additional Director (Non-Executive Nominee)

• Represents Clear Vision Investment Holdings Pte Ltd
• Nearly three decades of experience in financial services
• MBA from the University of Chicago Booth School of Business
• Associate Member of the Institute of Chartered Accountants of India
• Member of the Singapore Institute of Directors

Mr. Suresh Eshwara Prabhala

• Resigned as Non-Executive Nominee Director
• Simultaneously reappointed as Additional Director (Non-Executive Non-Independent)
• Over 25 years of experience in the finance industry
• Previously held positions at Mount Kellett Capital and J.P. Morgan
• MBA from the Indian Institute of Management in Calcutta

Implications and Expertise

The board restructuring brings a diverse set of skills to Tarsons Products. Dr. Mitra's extensive medical background aligns with the company's focus on life sciences, potentially enhancing its research and development initiatives. Mr. Arun Kumar's financial acumen and global experience are expected to contribute to the company's strategic financial planning and international operations.

Mr. Prabhala's transition from a nominee director to a non-independent role suggests a continued commitment to the company, leveraging his long-standing experience in finance and investment.

Governance and Compliance

All appointments are subject to shareholder approval, demonstrating Tarsons Products' commitment to corporate governance. The changes were recommended by the Nomination and Remuneration Committee and approved by the Board through circular resolution, ensuring a structured and compliant decision-making process.

Looking Ahead

These board changes come at a time when Tarsons Products is positioning itself for future growth in the competitive life sciences sector. The new board composition brings together expertise in medicine, finance, and corporate strategy, potentially setting the stage for innovative approaches and expanded market opportunities.

As Tarsons Products navigates the evolving landscape of the life sciences industry, the refreshed board structure appears poised to guide the company through its next phase of development and expansion.

Tarsons Products Limited , a leading player in the laboratory equipment industry, has announced the appointment of Mrs. Divya Sameer Momaya as a Non-Executive Independent Director. The appointment, effective from May 24, 2025, for a five-year term, received overwhelming support from shareholders through a postal ballot process.

Shareholder Approval

The special resolution for Mrs. Momaya's appointment was passed with a resounding majority. Out of the total 4,14,41,789 votes cast, representing 77.89% of the company's total paid-up equity share capital, an impressive 99.99% were in favor of the appointment. Only 0.01% of the votes were cast against the resolution.

Voting Breakdown

The voting results revealed strong support across different shareholder categories:

About Divya Sameer Momaya

Mrs. Momaya brings over 22 years of experience to Tarsons Products Limited, with expertise in:

• Corporate and secretarial laws
• Corporate governance
• Business development
• Startups
• Mentoring and consulting

Her educational background includes a Bachelor's degree in Commerce from the University of Pune. She has been an Associate Member of the Institute of Company Secretaries of India (ICSI) since 2003.

Professional Background

Mrs. Momaya's professional journey includes:

• Previous roles at BSE Limited and BSEL Infrastructure Realty Limited
• Current position as Partner at D.S. Momaya & Co. LLP
• Founding Director of MMB Advisors Private Limited
• Associations with Motilal Oswal, GTPL Hathway, and Blue Jet Healthcare

Independence and Compliance

The company has confirmed that Mrs. Momaya is not related to any existing director of Tarsons Products Limited. Additionally, she is not debarred from holding the office of director by the Securities and Exchange Board of India (SEBI) or any other authority.

The appointment of Mrs. Divya Sameer Momaya as an Independent Director is expected to bring valuable insights and expertise to Tarsons Products Limited's board, contributing to the company's continued growth and governance.